A phase II multicenter, randomized, double-blind, placebo-control clinical study evaluating the safety and efficacy of UA007 of preventing chemotherapy induced diarrhea in patients with colorectal cancer receiving chemotherapy containing FOLFIRI
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/47645
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Part A 1:UA007 D1, 2, 3 + FOLFIRI;Part A 2:PBO D1 + UA007 D2, 3 + FOLFIRI;Part A 3:UA007 once daily for 3 days + FOLFIRI;Part A extension 1:UA007 + FOLFIRI;Part A extension 2:PBO + FOLFIRI;Part B 1:UA007 + FOLFIRI;Part B 2:PBO + FOLFIRI
Primary outcome(s): Incidence rate of CID (chemotherapy induced diarrhea) in Cycle 1 to Cycle 3 that grade is >= 3
Study Design: Parallel
创建时间：
2022-09-15
